NO992468L - Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs - Google Patents

Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs

Info

Publication number
NO992468L
NO992468L NO992468A NO992468A NO992468L NO 992468 L NO992468 L NO 992468L NO 992468 A NO992468 A NO 992468A NO 992468 A NO992468 A NO 992468A NO 992468 L NO992468 L NO 992468L
Authority
NO
Norway
Prior art keywords
nsaids
treatment
composition
gastrointestinal disorders
containing bismuth
Prior art date
Application number
NO992468A
Other languages
Norwegian (no)
Other versions
NO992468D0 (en
Inventor
Jonathan Davidson Kaunitz
Owen Rickford Carryl
Shin Tanaka
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992468D0 publication Critical patent/NO992468D0/en
Publication of NO992468L publication Critical patent/NO992468L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Foreliggende oppfinnelse vedrører fremgangsmåter og sammen- setninger for å behandle en gastrointestinal forstyrrelse forårsaket eller mediert av Helicobacter pylori, hvilke omfatter vismut, og en gastropatisk mengde av et ikke- steroidalt anti-inflammatorisk medikament. Oppfinnelsen kan ytterligere inneholde terapeutiske effektive mengder av ett eller flere anti-sekretoriske medikamenter.The present invention relates to methods and compositions for treating a gastrointestinal disorder caused or mediated by Helicobacter pylori, which includes bismuth, and a gastropathic amount of a non-steroidal anti-inflammatory drug. The invention may further contain therapeutically effective amounts of one or more anti-secretory drugs.

NO992468A 1996-11-22 1999-05-21 Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs NO992468L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
PCT/US1997/021462 WO1998022118A1 (en) 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Publications (2)

Publication Number Publication Date
NO992468D0 NO992468D0 (en) 1999-05-21
NO992468L true NO992468L (en) 1999-07-01

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992468A NO992468L (en) 1996-11-22 1999-05-21 Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs

Country Status (7)

Country Link
EP (1) EP0941102A1 (en)
CN (1) CN1238694A (en)
CA (1) CA2271381A1 (en)
HU (1) HUP9904073A3 (en)
NO (1) NO992468L (en)
TR (1) TR199901101T2 (en)
WO (1) WO1998022118A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2000050037A1 (en) * 1999-02-26 2000-08-31 Nitromed, Inc. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
KR100887912B1 (en) * 2000-12-01 2009-03-12 다케다 야쿠힌 고교 가부시키가이샤 Process for the crystallization of r- or s-lansoprazole
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
EP1552833B1 (en) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Process for producing an amorphous optically active isomer of lansoprazole
JP5563735B2 (en) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド PPI multiple dosage form
KR101148399B1 (en) * 2005-06-22 2012-05-23 일양약품주식회사 Pharmaceutical Composition for Treating Gastric Disease Containing Antiulcerent and Mucosal Protective Agents
JP2011513202A (en) 2008-03-10 2011-04-28 武田薬品工業株式会社 Crystals of benzimidazole compounds
EP2344139A1 (en) 2008-09-09 2011-07-20 AstraZeneca AB Method for delivering a pharmaceutical composition to patient in need thereof
EA201290026A1 (en) 2009-06-25 2012-07-30 Астразенека Аб A METHOD FOR TREATING A PATIENT THAT HAS A RISK OF DEVELOPMENT OF ANALISM ASSOCIATED WITH THE RECEPTION OF NONSTEROID ANTI-INFLAMMATORY MEDIA
BR112014016085A8 (en) 2011-12-28 2017-07-04 Pozen Inc Enhanced compositions and methods for delivery of omeprazole plus acetylsalicylic acid
WO2023143573A1 (en) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 Use of bismuth-containing compound in treatment of diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A (en) * 1990-01-09 1991-07-10 Gist Brocades Nv ORAL PHARMACEUTICAL COMPOSITION.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
BR9206796A (en) * 1991-11-22 1995-05-02 Procter & Gamble Unit dose form of bismuth subsalicylate
DE69228738D1 (en) * 1991-12-06 1999-04-29 Glaxo Group Ltd Inflammatory or analgesic compositions containing ranitidine bismuth citrate and an NSAID

Also Published As

Publication number Publication date
HUP9904073A2 (en) 2000-03-28
CN1238694A (en) 1999-12-15
HUP9904073A3 (en) 2000-04-28
TR199901101T2 (en) 1999-07-21
CA2271381A1 (en) 1998-05-28
EP0941102A1 (en) 1999-09-15
WO1998022118A1 (en) 1998-05-28
NO992468D0 (en) 1999-05-21

Similar Documents

Publication Publication Date Title
NO992468L (en) Composition for the treatment of gastrointestinal disorders containing bismuth and NSAIDs
AU646230B2 (en) Pharmaceutical compositions and methods for treating the symptoms of overindulgence
DK1586322T3 (en) Compositions containing thalidomide and dextamethasone for the treatment of cancer
NO992469L (en) Compositions containing bismuth and NSAIDs and one or more antimicrobial agents for the treatment of gastrointestinal disorders
DK0754176T3 (en) Newly known carbamates and ureas as modifiers for multidrug resistance
PT862424E (en) PHARMACEUTICAL COMPOSITIONS UNDERSTANDING FLURBIPROFEN
DE69621012D1 (en) USE OF NSAIDS FOR THE TREATMENT OF squamous cell carcinoma of the oral cavity and throat
DK0600725T3 (en) Pharmaceutical compositions containing a guanidinothiazole compound and antacids
DK1024815T3 (en) Pharmaceutical composition for oral administration of molecular iodine
IT1212778B (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND / OR ANALGESIC ADAPTERITY, NON ULCEROGENE.
PT705100E (en) THERAPEUTIC SUBSTITUTED GUANIDINS
NO976048D0 (en) Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders
DE69009684D1 (en) Pharmaceutical compositions for the treatment of gastrointestinal disorders.
DK0697862T3 (en) Pharmaceutical compositions and methods employing isobutyramide for the treatment of beta-globin disorders
DK1032556T3 (en) Pharmaceutically active compounds and methods of use
DE69927584D1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF STOMACH DISEASES
NO954073L (en) Compositions for Inhibition, Control and Regression of Angiogenesis Containing Hyaluronic Acid and NSAIDs
TR199800421A2 (en) Bismuth salts of moenomycin group antibiotics.
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
DK554585A (en) PHARMACEUTICAL INCLUDING A COMPOUND OF AT LEAST ONE IMMUNOTOXIN AND AT LEAST ONE MANNOSE-CONTAINING POLYMER
DK1073436T3 (en) Improved method for eradication of Helicobacter pylori
NO982562L (en) Composition for the treatment of pain
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
ATE44461T1 (en) ANALGESIC COMPOSITIONS.
SE8504612D0 (en) ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS INCLUDING DIPHENHYDRAMIN AND PROCEDURES FOR USING THESE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application